HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Philippe Annereau Selected Research

F14512

1/2016F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.
12/2011Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
12/2008F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Philippe Annereau Research Topics

Disease

10Neoplasms (Cancer)
01/2016 - 06/2003
2Melanoma (Melanoma, Malignant)
02/2013 - 04/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011 - 10/2009
1Kidney Diseases (Kidney Disease)
01/2023
1Agenesis of Cerebellar Vermis
01/2023
1Senior Loken Syndrome
01/2023
1Ciliopathies
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2016
1Ovarian Epithelial Carcinoma
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2009
1Lung Neoplasms (Lung Cancer)
06/2009
1Neuroblastoma
06/2009
1Glioblastoma (Glioblastoma Multiforme)
06/2009
1Rhabdomyosarcoma
06/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2009
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2009
1Breast Neoplasms (Breast Cancer)
12/2008
1Leukemia L1210
12/2008
1Colonic Neoplasms (Colon Cancer)
08/2008
1Carcinoma (Carcinomatosis)
11/2005

Drug/Important Bio-Agent (IBA)

3Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2016 - 12/2008
3PolyaminesIBA
01/2016 - 12/2008
3F14512IBA
01/2016 - 12/2008
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
04/2005 - 08/2004
2Cisplatin (Platino)FDA LinkGeneric
01/2016 - 11/2005
2Etoposide (VP 16)FDA LinkGeneric
01/2016 - 12/2011
2SpermineIBA
12/2011 - 12/2008
2DNA (Deoxyribonucleic Acid)IBA
12/2011 - 12/2008
2Proteins (Proteins, Gene)FDA Link
06/2009 - 08/2008
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2004 - 06/2003
1Retinaldehyde (Retinal)IBA
01/2023
1Dinoprostone (PGE2)FDA Link
01/2022
1PlatinumIBA
01/2016
1Carboplatin (JM8)FDA LinkGeneric
01/2016
1cryptopleurineIBA
01/2015
1NestinIBA
02/2013
1Podophyllotoxin (Condylox)FDA LinkGeneric
12/2011
1PoisonsIBA
12/2011
1RNA (Ribonucleic Acid)IBA
10/2009
1triptolideIBA
10/2009
1Anaplastic Lymphoma KinaseIBA
06/2009
1F 91874IBA
06/2009
1PutrescineIBA
12/2008
1SpermidineIBA
12/2008
1Antineoplastic Agents (Antineoplastics)IBA
12/2008
1LuciferasesIBA
08/2008
1UbiquitinIBA
08/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2008
1Ether (Diethyl Ether)IBA
11/2005
1Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
11/2005
1RNA IsoformsIBA
04/2005
1multidrug resistance-associated protein 1IBA
12/2004
1Messenger RNA (mRNA)IBA
08/2004

Therapy/Procedure

4Therapeutics
01/2016 - 04/2005
1Drug Therapy (Chemotherapy)
08/2004